Your browser doesn't support javascript.
loading
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.
Vychytilova-Faltejskova, Petra; Merhautova, Jana; Machackova, Tana; Gutierrez-Garcia, Irene; Garcia-Solano, José; Radova, Lenka; Brchnelova, Dominika; Slaba, Katerina; Svoboda, Marek; Halamkova, Jana; Demlova, Regina; Kiss, Igor; Vyzula, Rostislav; Conesa-Zamora, Pablo; Slaby, Ondrej.
Afiliação
  • Vychytilova-Faltejskova P; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Merhautova J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Machackova T; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Gutierrez-Garcia I; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Garcia-Solano J; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Radova L; Department of Clinical Analysis, Santa Lucia University Hospital, Cartagena, Spain.
  • Brchnelova D; Department of Pathology, Santa Lucia University Hospital, Cartagena, Spain.
  • Slaba K; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Svoboda M; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Halamkova J; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Demlova R; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Kiss I; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Vyzula R; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Conesa-Zamora P; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Slaby O; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Oncogenesis ; 6(11): 399, 2017 Dec 04.
Article em En | MEDLINE | ID: mdl-29199273
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article